An investigation for investors in NASDAQ:RLYP shares was announced concerning whether the acquisition of Relypsa Inc. for $32.00 per share is unfair to NASDAQ:RLYP stockholders.
Investors who purchased shares of Relypsa Inc (NASDAQ:RLYP) and currently hold any of those NASDAQ:RLYP shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain directors of Relypsa Inc breached their fiduciary duties owed to NASDAQ:RLYP investors in connection with the proposed acquisition.
On July 21, 2016, Galenica Group (SIX:GALN) and Relypsa, Inc.(NASDAQ:RLYP) announced that the companies have entered into an agreement under which Galenica Group will acquire Relypsa Inc (NASDAQ:RLYP). Under the terms of the merger agreement, Galenica will pay $32 per share in cash, or a total of approximately$1.53 billion.
However, given that at least one analyst has set the high target price for NASDAQ:RLYP shares at $51.00 per share, the investigation concerns whether the offer is unfair to NASDAQ:RLYP stockholders. More specifically, the investigation concerns whether the Relypsa Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders’ best interests in connection with the proposed sale.
On July 29, 2016, NASDAQ:RLYP shares closed at $31.94 per share.
Those who are current investors in NASDAQ:RLYP shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego